You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address